Hyeon-Man Baek1, Yun-Ju Lee1, Eun-Hee Kim1, Chaejoon Cheong1, Seung-Ho Yang2
1Division of Magnetic Resonance, Korea Basic Science Institute, Ochang, Chungbuk, Korea; 2Neurosurgery St. Vincent's Hospital, Catholic University, Suwon, Gyeonggi-do, Korea
We present here that the data analysis of 1H- and 13C-NMR spectra of the tumor extracts can demonstrate a significant increase in the concentration of 2HG in IDH mutated tumors. On 13C-NMR spectra, 2HG peaks for each of the 5 carbons were detected in the IDH1 mutated but not IDH wild type tumors. 2HG 13C-resonances (C3, C4, C2, C1, and C5) were detected at 31.70, 34.18, 72.79, 181.95, and 183.56 ppm. It is expected that 2HG may be actively being produced during the period of 13C-substrate infusion (e.g., [U-13C]-glucose). Therefore, the present study demonstrates the feasibility of 1H- and 13C-NMR spectroscopy in the detection of 2HG as a novel biomarker of IDH mutation status in glioma.